FORT WORTH, Texas — Virbac has announced the introduction of palatable RILEXINE^® (cephalexin) Chewable Tablets for Dogs, the first FDA-approved cephalexin designed exclusively for veterinary medicine, to aid veterinarians and pet owners in the treatment of secondary superficial bacterial pyoderma caused by susceptible strains of Staphylococcus pseudintermedius.

New treatment helps control adrenal gland cortical disease in ferrets with a dissolvable implant.

FORT WORTH, TX—August 10, 2012 – Virbac announces the indexing of SUPRELORIN F Implant, a new, non-surgical treatment for ferrets suffering from adrenal gland cortical disease, delivered via a dissolvable, controlled-release implant.

Fort Worth, Texas — Virbac is proud to announce the 25th anniversary of C.E.T.^® Home Dental Care. With 25 years of leadership in veterinary home dental care, C.E.T. products are the most tenured veterinary brands in the market today. In addition to pioneering the home dental care market, Virbac has made numerous strategic decisions throughout the years to increase dental education and deliver relevant products to the veterinary community. 

FORT WORTH, Texas — Results from a combination of new research studies of aged dogs and cats suggest NOVIFIT^® (NoviSAMe^®) Tablets can diminish the effects of age-related cognitive dysfunction. Collectively, the results also support the use of NOVIFIT Tablets supplementation for cognitive dysfunction syndrome (CDS) in senior dogs and cats, especially for those in the early stages of the disease.

FORT WORTH, Texas — Virbac is proud to announce the smashing success of their recent C.E.T^® VEGGIEDENT^® promotion thanks to more than 1000 participating veterinary clinics. For each bag of C.E.T^® VEGGIEDENT^® Chews sold during the months of September and October, Virbac pledged to donate one dollar in support to the New Horizons Service Dogs. These funds will go directly to help fund service dogs in training and general company operations.